Magle Chemoswed Holding Investor Relations Material

Magle Chemoswed Holding AB is a company active in the pharmaceutical and medical device industries, serving as a contract development and manufacturing organization (CDMO). The company is dedicated to offering a wide range of services from development through manufacturing on a contract basis, excelling in bringing innovations from idea to product. Magle Chemoswed operates through its subsidiaries, including Magle Chemoswed AB and Adroit Science AB, focusing on the process development and manufacturing of Active Pharmaceutical Ingredients (API) and the development and manufacturing of products in wound care and diagnostics, particularly those based on degradable starch microspheres. Additionally, it provides consultancy in material characterization and solid-phase analysis, mainly targeting pharmaceutical companies. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.